Brent C. Behrens

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion

Thomas C. Hamilton, Margaret A. Winker, Karen G. Louie et al. · Biochemical Pharmacology · 1985 · 541 citations

Medicine, Cisplatin Cytotoxicity, Pharmacology +8

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

Brent C. Behrens, Thomas C. Hamilton, Hidetaka Masuda et al. · PubMed · 1987 · 500 citations

Chemoprevention Strategy, Oncogenic Agent, Medicine +12

Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine.

Karen G. Louie, Brent C. Behrens, Timothy J. Kinsella et al. · PubMed · 1985 · 333 citations

Radiation Medicine, Oncology, Buthionine Sulfoximine +14

Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione

Robert F. Ozols, Karen G. Louie, Jacqueline Plowman et al. · Biochemical Pharmacology · 1987 · 205 citations

Buthionine Sulfoximine Depletion, Oncogenic Agent, Medicine +9

Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice.

Thomas C. Hamilton, Robert C. Young, Karen G. Louie et al. · PubMed · 1984 · 156 citations

Pathology, Gynecology, Massive Ascites +17